JP2005530842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005530842A5 JP2005530842A5 JP2004515837A JP2004515837A JP2005530842A5 JP 2005530842 A5 JP2005530842 A5 JP 2005530842A5 JP 2004515837 A JP2004515837 A JP 2004515837A JP 2004515837 A JP2004515837 A JP 2004515837A JP 2005530842 A5 JP2005530842 A5 JP 2005530842A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- methacrylate
- group
- pharmaceutically active
- delivery system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/175,716 US20040043067A1 (en) | 2002-06-19 | 2002-06-19 | Fluorosiloxane matrix controlled diffusion drug delivery systems |
| PCT/US2003/019026 WO2004000288A1 (en) | 2002-06-19 | 2003-06-16 | Fluorosiloxane matrix controlled diffusion drug delivery system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005530842A JP2005530842A (ja) | 2005-10-13 |
| JP2005530842A5 true JP2005530842A5 (https=) | 2006-07-27 |
Family
ID=29999052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004515837A Pending JP2005530842A (ja) | 2002-06-19 | 2003-06-16 | フルオロシロキサンマトリックス制御拡散薬物送達システム |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040043067A1 (https=) |
| EP (1) | EP1515705B1 (https=) |
| JP (1) | JP2005530842A (https=) |
| CN (1) | CN1662227A (https=) |
| AU (1) | AU2003238247A1 (https=) |
| BR (1) | BR0311963A (https=) |
| CA (1) | CA2489987A1 (https=) |
| CZ (1) | CZ200537A3 (https=) |
| DE (1) | DE60306379T2 (https=) |
| ES (1) | ES2261947T3 (https=) |
| MX (1) | MXPA04012897A (https=) |
| PL (1) | PL375000A1 (https=) |
| RU (1) | RU2307667C2 (https=) |
| TW (1) | TW200404569A (https=) |
| UA (1) | UA80433C2 (https=) |
| WO (1) | WO2004000288A1 (https=) |
| ZA (1) | ZA200409979B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7922702B2 (en) | 2004-07-02 | 2011-04-12 | Qlt Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
| US7544371B2 (en) * | 2005-12-20 | 2009-06-09 | Bausch + Lomb Incorporated | Drug delivery systems |
| US20070148244A1 (en) * | 2005-12-22 | 2007-06-28 | Kunzler Jay F | Drug delivery systems |
| US20070218103A1 (en) * | 2006-03-15 | 2007-09-20 | Bausch & Lomb Incorporated | Rate controlled release of a pharmaceutical agent in a biodegradable device |
| US20070218104A1 (en) * | 2006-03-15 | 2007-09-20 | Bausch & Lomb Incorporation | Rate controlled release of a pharmaceutical agent in a biodegradable device |
| SG170816A1 (en) | 2006-03-31 | 2011-05-30 | Qlt Plug Delivery Inc | Drug delivery methods, structures, and compositions for nasolacrimal system |
| US7579021B2 (en) * | 2006-09-27 | 2009-08-25 | Bausch & Lomb Incorporated | Drug delivery systems based on degradable cationic siloxanyl macromonomers |
| UY30883A1 (es) * | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
| US9011361B2 (en) | 2007-09-07 | 2015-04-21 | Mati Therapeutics Inc. | Lacrimal implant detection |
| JP5599712B2 (ja) * | 2007-10-05 | 2014-10-01 | インターフェース バイオロジクス，インコーポレーテッド | オリゴフッ素化架橋ポリマーおよびそれの使用 |
| EP2389221B1 (en) * | 2009-01-23 | 2023-08-16 | Mati Therapeutics Inc. | Sustained released delivery of one or more agents |
| US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
| EP3290024B1 (en) | 2011-08-29 | 2019-04-17 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| CA1295941C (en) * | 1985-08-16 | 1992-02-18 | Rajan Bawa | Sustained-release formulation comprising a hydrophobic polymer system |
| IL91398A (en) * | 1988-08-30 | 1994-05-30 | Pfizer | Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane |
| US4882377A (en) * | 1988-09-21 | 1989-11-21 | Dow Corning Corporation | Low-viscosity pressure-adherent silicone elastomer compositions |
| US5321108A (en) * | 1993-02-12 | 1994-06-14 | Bausch & Lomb Incorporated | Fluorosilicone hydrogels |
| US5463010A (en) * | 1993-11-12 | 1995-10-31 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Hydrocyclosiloxane membrane prepared by plasma polymerization process |
| US6322815B1 (en) * | 1994-07-22 | 2001-11-27 | W. Mark Saltzman | Multipart drug delivery system |
| BR9612119A (pt) * | 1995-12-07 | 1999-02-17 | Bausch & Lomb | Unidade monomérica composição de hidrogel lente de contato e método para produzir uma composição de hidrogel |
| US5714557A (en) * | 1995-12-07 | 1998-02-03 | Bausch & Lomb Incorporated | Monomeric units useful for reducing the modulus of low water polymeric silicone compositions |
| US6296873B1 (en) * | 1997-01-23 | 2001-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release delivery system for carbamazephine derivatives |
| BR9809064A (pt) * | 1997-04-03 | 2002-01-02 | Guilford Pharm Inc | Polìmeros biodegradáveis de poliéster de tereftalato-polifosfato, composições, artigos e métodos para fazer e usar os mesmos |
| US5908996A (en) * | 1997-10-24 | 1999-06-01 | Timewarp Technologies Ltd | Device for controlling a musical performance |
| US6312728B1 (en) * | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
| TW200800298A (en) * | 2000-01-27 | 2008-01-01 | Zentaris Ag | Compressed microparticles for dry injection |
-
2002
- 2002-06-19 US US10/175,716 patent/US20040043067A1/en not_active Abandoned
-
2003
- 2003-06-16 AU AU2003238247A patent/AU2003238247A1/en not_active Abandoned
- 2003-06-16 JP JP2004515837A patent/JP2005530842A/ja active Pending
- 2003-06-16 CN CN038144662A patent/CN1662227A/zh active Pending
- 2003-06-16 RU RU2005100840/04A patent/RU2307667C2/ru not_active IP Right Cessation
- 2003-06-16 DE DE60306379T patent/DE60306379T2/de not_active Expired - Fee Related
- 2003-06-16 UA UAA200500490A patent/UA80433C2/uk unknown
- 2003-06-16 ES ES03737141T patent/ES2261947T3/es not_active Expired - Lifetime
- 2003-06-16 MX MXPA04012897A patent/MXPA04012897A/es active IP Right Grant
- 2003-06-16 WO PCT/US2003/019026 patent/WO2004000288A1/en not_active Ceased
- 2003-06-16 EP EP03737141A patent/EP1515705B1/en not_active Expired - Lifetime
- 2003-06-16 CA CA002489987A patent/CA2489987A1/en not_active Abandoned
- 2003-06-16 CZ CZ20050037A patent/CZ200537A3/cs unknown
- 2003-06-16 PL PL03375000A patent/PL375000A1/xx not_active Application Discontinuation
- 2003-06-16 BR BR0311963-7A patent/BR0311963A/pt not_active IP Right Cessation
- 2003-06-18 TW TW092116547A patent/TW200404569A/zh unknown
-
2004
- 2004-12-09 ZA ZA200409979A patent/ZA200409979B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005530842A5 (https=) | ||
| JP2002348393A5 (https=) | ||
| US20060018949A1 (en) | Injectable biodegradable drug delivery system | |
| EP2109442B1 (en) | Ophthalmic compositions containing a synergistic combination of three polymers | |
| JP7419499B2 (ja) | 湿式充填のソフトヒドロゲル眼用インサート | |
| JP2004536633A5 (https=) | ||
| CA2491312A1 (en) | Bioerodible film for ophthalmic drug delivery | |
| AU2006210416A1 (en) | Contact drug delivery system | |
| JP2007509902A5 (https=) | ||
| WO2004090613A1 (ja) | 薬物徐放性眼用レンズ及びそれに用いる保存液 | |
| US20220380761A1 (en) | Oral delivery of oligonucleotides | |
| RU2005100840A (ru) | Фторсилоксановые матриксные системы доставки лекарств с регулируемой диффузией | |
| CA2325386A1 (en) | Hydrogel compositions useful for the sustained release of macromolecules and methods of making same | |
| JP2004534739A5 (https=) | ||
| CN117545509A (zh) | 寡核苷酸的口服递送 | |
| JPS62103028A (ja) | 疎水性ポリマ−系を含む持効性製剤 | |
| JP2010504318A5 (https=) | ||
| US20060078592A1 (en) | Drug delivery systems | |
| CN1644215A (zh) | 一种眼用嵌段聚合物 | |
| Schacht | Hydrogel drug delivery systems physical and ionogenic drug carriers | |
| US20060198892A1 (en) | Polymeric systems for controlled drug therapy | |
| JP2025136503A (ja) | 眼表面薬物滞留化剤および該剤を含有する点眼剤 | |
| US20240207409A1 (en) | Oral delivery of oligonucleotides | |
| KR20050021025A (ko) | 플루오로실록산 매트릭스 조절 확산 약물 전달계 | |
| JPWO1999026637A1 (ja) | 眼科用剤及び眼科用組成物 |